2002
DOI: 10.1083/jcb.200209004
|View full text |Cite
|
Sign up to set email alerts
|

A novel Apaf-1–independent putative caspase-2 activation complex

Abstract: CVaspase activation is a key event in apoptosis execution. In stress-induced apoptosis, the mitochondrial pathway of caspase activation is believed to be of central importance. In this pathway, cytochrome c released from mitochondria facilitates the formation of an Apaf-1 apoptosome that recruits and activates caspase-9. Recent data indicate that in some cells caspase-9 may not be the initiator caspase in stress-mediated apoptosis because caspase-2 is required upstream of mitochondria for the release of cytoch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
128
1
1

Year Published

2004
2004
2013
2013

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 154 publications
(138 citation statements)
references
References 29 publications
8
128
1
1
Order By: Relevance
“…It is activated similarly to other initiator caspases via induced proximity dimerization and autocatalytic processing within an adaptor protein complex, and it appears to function, at least under some circumstances, upstream of the mitochondria (Baliga et al 2004). The current model for caspase-2 activation involves two adaptor proteins, PIDD ( p53-induced protein with a death domain) and RAIDD (RIP-associated ICH-1/CED-3 homologous proteins with a death domain) (Duan and Dixit 1997;Read et al 2002;Tinel and Tschopp 2004). Together, these proteins form the PIDDosome complex, which consists of five PIDDs, seven RAIDDs, and seven caspase-2 molecules .…”
Section: Caspase Activationmentioning
confidence: 99%
“…It is activated similarly to other initiator caspases via induced proximity dimerization and autocatalytic processing within an adaptor protein complex, and it appears to function, at least under some circumstances, upstream of the mitochondria (Baliga et al 2004). The current model for caspase-2 activation involves two adaptor proteins, PIDD ( p53-induced protein with a death domain) and RAIDD (RIP-associated ICH-1/CED-3 homologous proteins with a death domain) (Duan and Dixit 1997;Read et al 2002;Tinel and Tschopp 2004). Together, these proteins form the PIDDosome complex, which consists of five PIDDs, seven RAIDDs, and seven caspase-2 molecules .…”
Section: Caspase Activationmentioning
confidence: 99%
“…Although caspase-2 was one of the first apoptotic caspases discovered, its physiological function remains a matter of considerable debate and somewhat of an enigma. Caspase-2 contains a CARD that facilitates dimerisation of procaspase-2 molecules, 97,98 interaction with CARD-containing protein RAIDD 99 or recruitment to large multiprotein complexes, 100 events that trigger procaspase-2 activation. Caspase-2 is recruited into a protein complex similar to the Apaf-1/caspase-9 apoptosome.…”
Section: The Apoptotic Caspases S Kumarmentioning
confidence: 99%
“…However, the inherent cleavage site specificity of caspases have been applied to make active site probes that show some degree of selectivity for individual caspases, 10 and when these are coupled with selective antisera the identity of active caspases in complex mixtures is more readily disclosed. [11][12][13][14] Specificity for protein substrates Exosites. Having a preferred cleavage site specificity is not sufficient for proteolysis of natural proteins; appropriate presentation of the cleavage site seems critical for efficient hydrolysis.…”
Section: What It Takes To Be a Caspasementioning
confidence: 99%